Diethylstilbestrol should never be used in pregnant women because it is associated with:
**Core Concept**
Diethylstilbestrol (DES) is a synthetic form of estrogen that has been used in various medical conditions, including cancer treatment and hormone replacement therapy. However, its use in pregnant women poses significant risks due to its teratogenic effects.
**Why the Correct Answer is Right**
DES is a potent estrogen agonist that can interfere with fetal development, particularly the reproductive system. When used during pregnancy, DES can cause a range of abnormalities, including clear cell adenocarcinoma of the vagina and cervix in daughters exposed in utero. This is due to the disruption of normal fetal development and the induction of abnormal cellular growth patterns. The exact mechanism is not fully understood, but it is believed to involve the binding of DES to estrogen receptors, which then alter gene expression and cellular behavior.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because DES is not primarily associated with cardiovascular disease. While estrogen therapy can have cardiovascular benefits, DES is not the correct answer in this context.
**Option B:** This option is incorrect because DES is not primarily associated with thyroid dysfunction. While thyroid disorders can be influenced by hormonal imbalances, DES is not the correct answer in this context.
**Option C:** This option is incorrect because DES is not primarily associated with anaphylaxis. While some medications can cause severe allergic reactions, DES is not the correct answer in this context.
**Clinical Pearl / High-Yield Fact**
DES is a classic example of a teratogenic agent, highlighting the importance of careful consideration of medications during pregnancy to avoid harm to the developing fetus.
**Correct Answer:** D. Clear cell adenocarcinoma of the vagina and cervix.